Positioning and Outlook - 2026-10-27
Published 2026-10-27
Japanese wholesale inflation and France's deepening debt troubles keep sovereign and rate uncertainty in play, while widening high-yield spreads and weak corporate credit-health scores add to a cautious credit backdrop as Cameco's November 3 earnings approach.
Recent Events
Japanese wholesale inflation stayed elevated and kept the Bank of Japan's rate-hike question alive, while France's debt troubles deepened as foreign investors looked for the exit, a reminder that the sovereign backdrop has not settled. On the credit side, high-yield spreads widened on the week, corporate credit-health scoring put the average at 48 out of 100 with 7,944 names flagged in danger, and buybacks kept climbing from $4,438 billion to $4,467 billion over the trailing year. The Fed's communication ran through supervisory modernization remarks from Bowman and Waller's discussion of the Summary of Economic Projections' signaling value, while Anthropic's confidential draft IPO filing sketched red-hot growth alongside steep computing costs and assorted risks. Days ahead bring Cameco's report on November 3, with the details laid out below.
Upcoming Events
The calendar ahead is built around a dense run of central-bank decisions, with the Federal Reserve, the European Central Bank and the Bank of Japan meeting on consecutive days at the end of October and the Bank of England following in early November, before China's loan prime rate fixing arrives later in the month. That clustering compresses the window in which the broad market can react, and it dominates a schedule otherwise made up of smaller, single-name events. Alongside the macro spine, the week of October 26 brings a heavy run of Treasury bill and note auctions, a pair of early-stage drug readouts, and an expected public S-1 from Anthropic, a filing worth watching for its potential liquidity and index-repricing effects. A busy earnings stretch of 2455 reports fills out the backdrop, with DINO, TZOO, THC, STX, TWO and ST among the first to land.
Macro Projections
The near-term outlook hinges on an unusually dense run of calendar events: the FOMC decision on 2026-10-28 tests the restrictive-hold consensus, PCE and GDP the following day can respectively revive inflation-hike pricing or validate the duration bid, and the ECB and BoJ decisions on 2026-10-29 and 2026-10-30 can either extend the global yield rally or reopen the carry shock, with alternative-asset-manager earnings through 2026-11-02 then serving as a private-credit check. The carry model's disorderly-unwind probability is falling rather than accelerating, at 34.85% and below its 39.79% trail peak, while its slow-motion-crack probability holds at 39.37%; its elevated-FX-volatility tag is discounted because ground-truth G7 FX volatility (how much the major-currency exchange rates are swinging) sits at -0.538 and is accelerating downward. The Fed model's intervention propensity is stable at 26.4% alongside 77.8% hold propensity and a 4 bp SOFR–funds spread, so the Fed model, Kalshi pricing and news flow all converge on a restrictive hold. Credit is where the models and the market part ways: the CCC/BB reading has accelerated downward from 3.511 to 1.9177 as of 2026-09-30, yet observed high-yield spreads widened from 3.03% on 2026-10-06 to 3.38% on 2026-10-23, so improving model internals do not yet equal market confirmation. Rates describe a global rally rather than a US-specific fiscal reprieve, the US 10Y at 4.986% sits only at its 61.6th historical percentile even after a 16 bp weekly decline, while the 30Y at 5.301% rests at its 94.4th, with Japan's 10Y down 12.1 bp to 2.837%, Germany's down 7.5 bp to 3.369%, the UK's down 3.1 bp to 5.278%, and US–JGB and US–Bund differentials narrowing to 2.149% and 1.617%. Against a 40.4 CAPE and a US earnings yield of 4.13% versus 5.82% developed ex-US and 6.98% emerging markets, that leaves little valuation cushion, and the geopolitical backdrop is elevated at a GPR reading of 165.2 with Iran/Hormuz near closure, Israel/Gaza kinetic, Houthi/Red-Sea insurance stress, Russia–Ukraine continuing and US–China technology tariffs escalating; crude risk is substantially priced, with Kalshi putting Brent above $104.50 on 2026-10-26 at 97%, while VIX at 19.45 and accelerating upward, VIX/VIX3M in contango at 0.95, MOVE stable at 102.2 bp and SKEW tail-heavy at 151.8 suggest equities have not priced the same tension. The conditional fork is explicit: roughly 30% odds of a calm-credit regime break by 2027-01-25, with high-yield spreads above 4.00% as the lead indicator, if that arrives by 2026-12-15, equity de-risking and easing repricing should follow; otherwise the base case is muddle-through of no near-term Fed move, contained credit and tactical duration. Kalshi prices a pre-2027 cut at only 6.1% against a conditional read nearer 15%, roughly nine points of underpriced easing tail, and confidence legitimately fades from the near-term hold toward that longer structural read, which fails if by 2027-01-25 high-yield spreads are below 3.00%, the 30Y Treasury is below 4.75%, and December CPI is no higher than 3.5%.
Positioning
Position weights scale to conviction, and conviction here is the screening-kernel composite, a modelled blend of expected upside drift against drawdown probability, so the highest-scoring names carry the largest equity weights while low-conviction names stay small. Set against a credit backdrop of elevated high-yield spreads near 3.38%, that sizing logic runs alongside a set of structural mechanisms, each carried with its historical base rate and discounted for what the market already prices. Those mechanisms are weighable inputs rather than predictions or guarantees, and the holdings and their underlying scores follow in the model-portfolio table.
| Name | Conviction score | Modelled drift |
|---|---|---|
| ET | 2.58 | +4.3% |
| NTR | 2.19 | +3.5% |
| CCJ | 2.13 | -0.6% |
| CF | 2.11 | +1.5% |
| NXE | 1.27 | -0.3% |
| LDOS | 0.97 | -4.2% |
Model Portfolio
The model portfolio holds a substantial cash position, with money-market exposure standing as dry powder reserved for staged deployment as the credit and volatility picture resolves. Around it sit two structural sleeves: a cluster of inflation-linked Treasury holdings expressing the financial-repression thesis, and a gold allocation serving as a geopolitical flight-to-quality and monetary-stress diversifier. The actively-managed equity sleeve leans toward quality, high return-on-capital, low leverage, with a tilt to the AI capex cycle, alongside a single midstream energy name.
| Name | Weight | Thesis |
|---|---|---|
| Cash · 41.9% | ||
| Money Market | 41.9% | money-market / cash |
| Equity · 11.7% | ||
| QUAL | 11.7% | global quality equity |
| Inflation-linked · 23.7% | ||
| SCHP | 11.4% | inflation-linked Treasuries |
| VTIP | 7.0% | inflation-linked Treasuries |
| LTPZ | 5.3% | inflation-linked Treasuries |
| Other · 15.6% | ||
| KMI | 5.2% | passthrough |
| LDOS | 1.9% | critical materials defense |
| CCJ | 1.5% | critical materials defense |
| FCX | 1.4% | critical materials defense |
| SCCO | 1.4% | critical materials defense |
| NXE | 0.9% | critical materials defense |
| LIT | 0.7% | critical materials defense |
| COPX | 0.7% | critical materials defense |
| URA | 0.5% | critical materials defense |
| URNM | 0.3% | critical materials defense |
| NTR | 0.3% | critical materials defense |
| MP | 0.3% | critical materials defense |
| CF | 0.2% | critical materials defense |
| SQM | 0.2% | critical materials defense |
| ICL | 0.1% | critical materials defense |
| ET | 0.0% | passthrough |
| Gold & metals · 7.1% | ||
| IAU | 5.1% | gold / precious-metals |
| GDX | 2.0% | gold / precious-metals |
Track Record
Since 2026-08-21, the model portfolio has returned -5.10% against -0.54% for a daily-rebalanced 60/40 blend, a relative shortfall of about 4.56% over 46 trading days. Across the evaluated picks, positive alpha grew scarcer as the horizon lengthened: 38% of outcomes at one day, 39% at one week, and 19% at four weeks, with mean alpha turning more negative at each step, though the four-week sample rests on 98 observations and the one-day figures include some outcomes still inside their window. The record reflects a fixed discipline, calls are written down before the outcome is known and scored when the horizon arrives, whatever the result, and the first three-month outcomes are not due until around 2026-11-20. All figures are hypothetical model performance, not an individual account's return, and past results do not guarantee future ones.
Macro forecasts: 440 graded, 1438 open — each call is scored against what actually happened when its horizon arrived.
DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)
This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.
This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.
Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.
[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].
POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.
CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.
MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.
Intended transactions: the affiliated automated system has open or queued target allocations in the following securities discussed here: LTPZ, QUAL, SCHP, VTIP. These are real pending orders or model target weights in accounts belonging to the publication's operator, disclosed for transparency under our Trading & Publication Policy [link] — not a recommendation, and our interests may differ from yours.
Positions held: the publisher and/or operator currently holds positions in the following securities discussed here: CCJ, CF, COPX, ET, FCX, GDX, IAU, ICL, KMI, LDOS, LIT, MP, NTR, NXE, SCCO, SQM, URA, URNM.